Cerdulatinib (PRT2070), acts as a novel oral and dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Preferentially selects for JAK inhibitors (JAK1 and JAK3 primarily), preventing cytokine mediated signaling and functional responses varying cell types. Potential anti-cancer agent. Molecular Formula: C20H27N7O3S Solubility: DMSO (Slightly), Methanol (Slightly, Heated) Molecular Weight: 445.54 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
445.54
Form:
Supplied as a Light Yellow Brown Solid
CAS Number:
[1198300-79-6]
* VAT and and shipping costs not included. Errors and price changes excepted
